- Strong strategic fit that increases presence in multiple high-growth adjacencies and offers immediate commercial impact from Waters’ proven execution model
- Doubles Waters’ total addressable market to approximately $40 billion, with 5-7% annual growth
- Creates a combined company with pro forma expected 2025 sales of approximately $6.5 billion and adjusted EBITDA of approximately $2.0 billion
- Increases annual recurring revenue to over 70% with over 80% of revenue coming from iconic market-leading brands
- Anticipate approximately $345 million in annualized EBITDA synergies by 2030, including $200 million of cost synergies by year three, and $290 million of revenue synergies by year five
- Delivers an industry-leading financial outlook with mid-to-high single-digit revenue growth, approximately 500 basis points of adjusted operating margin expansion, and mid-teens annualized adjusted EPS growth expected over five years
- Transaction expected to be accretive to adjusted EPS in the first year
Author Archive: AZBio
The R & D Expensing Fix in the One Big Beautiful Bill
New tax law restores immediate R&D expensing in the US
Life Sciences Workforce Collaborative Releases 2025 National Workforce Trends Report Amid Industry Crossroads
Boston, MA, June 24, 2025 – The Life Sciences Workforce Collaborative (LSWC), formerly the Coalition of State Bioscience Institutes (CSBI), today released its 2025 National Life Sciences Workforce Trends Report, the seventh edition of this landmark study, at the 2025 BIO International Convention in Boston.
Developed in partnership with TEConomy Partners, LLC, with support from InnovATEBIO, the National Biotechnology Education Center, the biennial report captures an evolving talent landscape across the U.S. life sciences sector. Drawing on survey responses from over 500 companies, 200 executive interviews, and 2.9 million job postings, the 2025 edition reflects a more complex, cautious industry posture as companies respond to macroeconomic pressures, talent availability, and rapid digital transformation.¹Continue reading
Working to diagnose valley fever more quickly
A rapid test, developed by an ASU professor working with Mayo Clinic, could be available for use by the end of the year.Continue reading
As Congress Focuses on the Budget – Life Science Leaders Focus on an EPIC solution.
From full page ads in the Boston Globe to panels of thought leaders at BIO 2025,and podcasts, leaders are highlighting the problems being created by the Pill Penalty that is part of the Inflation Reduction Act. As Congress works through the Budget Reconciliation Process, the EPIC Act could be a solution.Continue reading
Peter Pellerito, Senior Policy Advisor with Biotechnology Innovation Organization, Honored with AURP Vision Award
Tucson, AZ, and College Park, MD, June 20, 2025 – The Association of University Research Parks (AURP) this week presented the AURP Vision Award to Peter Pellerito, Senior Policy Advisor at the Biotechnology Innovation Organization (BIO), during the AURP BIO Health Caucus (held in advance of the BIO 2025 International Convention in Boston).Continue reading
Caris Life Sciences Completes Initial Public Offering (IPO)
Reuters reports that Caris Life Sciences raised $494.1 million in its Nasdaq initial public offering
Life Sciences Workforce Collaborative (LSWC) Officially Launches to Strengthen Talent Pipelines Across the U.S.
Formerly the Coalition of State Bioscience Institutes (CSBI), LSWC to drive national coordination and visibility for life sciences workforce development
Wexford Science & Technology Launches Pre-Leasing for 800 PBC
Builds on Momentum of PBC, ASU Health With 850 PBC Nearing Full CapacityContinue reading